Anderson Cynthia Lynn 4
4 · Vistagen Therapeutics, Inc. · Filed Aug 23, 2023
Insider Transaction Report
Form 4
Anderson Cynthia Lynn
CHIEF FINANCIAL OFFICER
Transactions
- Award
Stock Option (right to buy)
2023-08-21+8,333→ 8,333 totalExercise: $5.34Exp: 2033-08-21→ Common Stock (8,333 underlying)
Footnotes (2)
- [F1]25% of the stock options vest on August 21, 2024 (the "Vesting Start Date") and 1/36th of the remaining number of shares vest monthly thereafter until all awarded shares are fully vested three (3) years after the Vesting Start Date.
- [F2]The stock options were granted in connection with the Reporting Person's appointment as Chief Financial Officer and pursuant to the Issuer's 2019 Omnibus Equity Incentive Plan.